Company Overview of 3-V Biosciences, Inc.
3-V Biosciences, Inc. operates as a biopharmaceutical company that discovers and develops therapeutics for the treatment of oncology and infectious diseases. The company offers a TVB-2640, a fatty acid synthase inhibitor that blocks tumor cell signaling pathways and induces tumor cell apoptosis. It also focuses on developing antiviral therapeutic candidates for respiratory syncytial virus, cytomegalovirus, and other human pathogens. The company was incorporated in 2006 and is based in Menlo Park, California.
1050 Hamilton Court
Menlo Park, CA 94025
Founded in 2006
Key Executives for 3-V Biosciences, Inc.
3-V Biosciences, Inc. Key Developments
Similar Private Companies By Industry
|Joseph and Gionis, L.L.C.||United States|
|Atto BioScience, Inc.||United States|
|IDM Pharma, Inc.||United States|
|Intellia Therapeutics Inc.||United States|
|Genetic Medisyn Corp.||United States|
Recent Private Companies Transactions
October 22, 2014
To contact 3-V Biosciences, Inc., please visit www.3vbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.